Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Licenses DNA Amplification Technology from Genetrix

NEW YORK (GenomeWeb News) – Spanish biotechnology holding company Genetrix today announced it has licensed its Qualiphi polymerase product to Qiagen.

The global, exclusive deal was reached through Genetrix's X-Pol subsidiary.

Qualiphi is a DNA polymerase licensed from the Spanish National Research Council and studies suggest that it may improve the amplifications of whole genomes and large stretches of DNA, Genetrix said.

Financial and other terms of the deal were not disclosed.

Founded in 2011, Genetrix serves as an incubator for Spanish biotech companies established in academic settings. It has invested more than €36 million ($44.2 million) in nine companies with a focus on healthcare technologies, human therapies, and diagnostics.

X-Pol was created by Genetrix and Luis Blanco in 2008 and develops technologies for DNA amplification and sequencing. Genetrix owns 84 percent of the company.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.